Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 901–1,000 of 1,033
Müller, V., Viemann, D., Schmidt, M., Endres, N., Ludwig, S., Leverkus, M., Roth, J., & Goebeler, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8435 · Cited by 62
“I nvasive infections by pathogenic Candida species are a common cause of nosocomial bloodstream infections (1).”
BackgroundVelasco, E., & Bigni, R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0546-y · Cited by 59
“6 cases per 10,000 admissions and a crude mortality rate of 39% [1].”
BackgroundPre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR
Morad, H. O. J., Wild, A., Wiehr, S., Davies, G. E., Maurer, A., Pichler, B. J., & Thornton, C. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01996 · Cited by 71
“IC is now the fourth most common bloodstream infection, behind staphylococcal and enterococcal infections, although IC carries much higher rates of mortality (Wisplinghoff et al., 2004; Lewis, 2009).”
BackgroundChen, T., Feng, Y., Sun, W., Zhao, G., Wu, H., Cheng, X., Zhao, F., Zhang, L., Zheng, Y., Zhan, P., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.002 · Cited by 61
Sendra, E., Fernández-Muñoz, A., Zamorano, L., Oliver, A., Horcajada, J. P., Juan, C., & Gómez-Zorrilla, S. (2024) · Infection · doi:10.1007/s15010-024-02313-x · Cited by 75
Chan, L. C., Chaili, S., Filler, S. G., Barr, K., Wang, H., Kupferwasser, D., Edwards, J. E., Xiong, Y. Q., Ibrahim, A. S., Miller, L. S., et al. (2015) · Infection and Immunity · doi:10.1128/iai.01061-15 · Cited by 59
“aureus is the second most common bloodstream isolate in healthcare settings (7).”
BackgroundEvaluation of the antifungal potential of Brazilian Cerrado medicinal plants
Silva, F. M. E., de Paula, J. E., & Espíndola, L. S. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01647.x · Cited by 61
Redundant role of TLR9 for anti-Candida host defense
van de Veerdonk, F. L., NETEA, M., Jansen, T., JACOBS, L., Verschueren, I., van der Meer, J. W. M., & Kullberg, B. J. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.05.002 · Cited by 59
Li, R., Kumar, R., Tati, S., Puri, S., & Edgerton, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02295-12 · Cited by 60
“The incidence and mortality rates associated with this infectious disease have remained unchanged for more than a decade despite major advances in the field of antifungal therapy (6, 7).”
BackgroundAittakorpi, A., Kuusela, P., Koukila-Kähkölä, P., Vaara, M., Petrou, M. A., Gant, V. A., & Mäki, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01461-12 · Cited by 62
“are the 4th most common causative agents of nosocomial bloodstream infections (BSIs) in the United States and the 5th to 10th most common cause in Europe and Australia (6, 8, 36).”
BackgroundSecondary bile acids inhibit Candida albicans growth and morphogenesis
Guinan, J., Villa, P., & Thangamani, S. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty038 · Cited by 61
“Candida albicans, an opportunistic pathogen in the human gastrointestinal (GI) tract, causes life-threatening infections especially in immunocompromised individuals (Hajjeh et al. 2004; Wisplinghoff et al. 2004; Lockhart et al. 2012; Pfaller et al. 2012; Huffnagle and Noverr 2013).”
BackgroundA Re-Evaluation of the Relationship between Morphology and Pathogenicity in Candida Species
Kadosh, D., & Mundodi, V. (2020) · Journal of Fungi · doi:10.3390/jof6010013 · Cited by 70
“Sepsis caused by Candida albicans has an associated mortality rate of about 40%, which is higher than that of any bacterial sepsis [2,9,10].”
BackgroundGao, H., Evans, T. W., & Finney, S. J. (2008) · Critical Care · doi:10.1186/cc6862 · Cited by 67
Hasim, S., Allison, D. P., Retterer, S. T., Hopke, A., Wheeler, R. T., Doktycz, M. J., & Reynolds, T. B. (2017) · Infection and Immunity · doi:10.1128/iai.00601-16 · Cited by 58
“In addition to the glucan 77 polymers, the inner layer contains a small, but crucial amount of chitin, a linear β (1, 4)-linked N78 acetylglucosamine polymer.”
BackgroundLott, T. J., Frade, J. P., & Lockhart, S. R. (2010) · Eukaryotic Cell · doi:10.1128/ec.00002-10 · Cited by 58
“In the most recently available survey of nosocomial bloodstream infections, Candida species were the fourth most common organism, surpassed only by Staphylococcus and Enterococcus species (24).”
BackgroundPoole, N. M., Green, S. I., Rajan, A., Vela, L. E., Zeng, X., Estes, M. K., & Maresso, A. W. (2017) · Infection and Immunity · doi:10.1128/iai.00581-17 · Cited by 67
“coli (17, 51, 52), generally classified as ExPEC.”
BackgroundLiu, S., Fang, R., Zhang, Y., Chen, L., Huang, N., Yu, K., Zhou, C., Cao, J., & Zhou, T. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02250-x · Cited by 60
Interactions between Candida albicans and the resident microbiota
Li, H., Miao, M., Jia, C., Cao, Y.-B., Yan, T., Jiang, Y., & Yang, F. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.930495 · Cited by 72
“They are the fourth most common cause of nosocomial bloodstream infections and are the major fungal pathogens isolated from medical device infections (Wisplinghoff et al., 2004; Pfaller and Diekema, 2007).”
BackgroundHorino, T., Sato, F., Hosaka, Y., Hoshina, T., Tamura, K., Nakaharai, K., Kato, T., Nakazawa, Y., Yoshida, M., & Hori, S. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000350 · Cited by 59
Ahmed, S. H., Daef, E., Badary, M. S., Mahmoud, M. A., & Abd-Elsayed, A. A. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-76 · Cited by 82
“Similarly, in a nationwide study, a crude mortality rate as high as 27% has been reported [3].”
BackgroundResultA Review on the Clinical Use of Inhaled Amphotericin B
Kuiper, L., & Ruijgrok, E. J. (2009) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0715 · Cited by 58
Chou, H.-H., Lo, H., Chen, K.-W., Liao, M.-H., & Li, S. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.03.014 · Cited by 59
“Invasive Candida infections continue to cause major problems of morbidity and mortality in a diverse range of debilitated and immunocompromised hosts (Tortorano et al., 2003; Hajjeh et al., 2004; Wisplinghoff et al., 2004; Kao et al., 1999; Gudlaugsson et al., 2003).”
BackgroundTreatment Options for??Multidrug-Resistant Acinetobacter Species
Moran‐Gilad, J., & Carmeli, Y. (2008) · Drugs · doi:10.2165/00003495-200868020-00003 · Cited by 58
Sellam, A., Hogues, H., Askew, C., Tebbji, F., van het Hoog, M., Lavoie, H., Kumamoto, C. A., Whiteway, M., & Nantel, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-7-r71 · Cited by 58
“Background Candida albicans is an opportunistic pathogen responsible for various non life-threatening infections, such as oral thrush and vaginitis, and accounts for more than half of all Candida infections [1,2].”
Del Bono, V., Delfino, E., Furfaro, E., Mikulska, M., Nicco, E., Bruzzi, P., Mularoni, A., Bassetti, M., & Viscoli, C. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05408-11 · Cited by 58
“Candida has been reported to be one of the most frequent cause of associated bloodstream infections in different health care settings (16, 26, 28) and carries an attributable mortality ranging from 5 to 71% (8).”
BackgroundTwo-Component Signal Transduction Proteins as Potential Drug Targets in Medically Important Fungi
Chauhan, N., & Calderone, R. (2008) · Infection and Immunity · doi:10.1128/iai.00834-08 · Cited by 60
“Costs of patient care management are staggering and are most often associated with an increased length of stay in the hospital associated with a delayed therapeutic intervention and other problems (3, 45, 54, 70, 71).”
BackgroundCoagulase-negative staphylococci
David, M. D., & Elliott, T. (2015) · British Journal of Hospital Medicine · doi:10.12968/hmed.2015.76.8.c126 · Cited by 58
The Candida albicans ATO Gene Family Promotes Neutralization of the Macrophage Phagolysosome
Danhof, H. A., & Lorenz, M. C. (2015) · Infection and Immunity · doi:10.1128/iai.00984-15 · Cited by 57
“In contrast, amino acids appear abundant, since many (but not all) auxotrophic mutants retain full virulence (4, 50, 51).”
BackgroundDelisle, M.-S., Williamson, D. R., Albert, M., Perreault, M. M., Jiang, X., Day, A. G., & Heyland, D. K. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/827692 · Cited by 64
“All laboratories did not speciate isolates of Candida; thus, complete data were unavailable for analysis; it has been suggested that the Candida species may impact the outcome of patients developing invasive candidiasis (36).”
BackgroundShaping of cutaneous function by encounters with commensals
Barnard, E., & Li, H. (2016) · The Journal of Physiology · doi:10.1113/jp271638 · Cited by 68
“The ubiquitous nature of S. epidermidis on the human skin and its ability to form biofilms have resulted in a high incidence of S. epidermidis in hospital-acquired infections, medical device failure and even bacteraemia (Wisplinghoff et al. 2004; Rogers et al. 2009).”
BackgroundMihu, M. R., Cabral, V., Pattabhi, R., Tar, M. T., Davies, K. P., Friedman, A., Martinez, L. R., & Nosanchuk, J. D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02020-16 · Cited by 60
“CVCs are a high risk for staphylococcal biofilm-related infection due to the presence of bacteria in the skin and because they are in direct contact with the patient’s bloodstream; it is therefore no surprise that this organism is the leading cause of bloodstream infections in the United States (7).”
BackgroundInfluentialPhosphate Acquisition and Virulence in Human Fungal Pathogens
Ikeh, M. A. C., Ahmed, Y., & Quinn, J. (2017) · Microorganisms · doi:10.3390/microorganisms5030048 · Cited by 64
“hospital-acquired bloodstream infections with a mortality rate above 40% [3].”
Karumathil, D. P., Nair, M. S., Gaffney, J., Johny, A. K., & Venkitanarayanan, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01011 · Cited by 58
“In humans, MDR A. baumannii causes a wide-spectrum of clinical conditions, including pneumonia (Leung et al., 2005), blood-stream infections (Wisplinghoff et al., 2004; Centers for Disease Control and Prevention [CDC], 2004), meningitis (Metan et al., 2007), urinary tract infections (Sunenshine et…”
BackgroundVascular Catheter-Associated Infections: A Microbiological and Therapeutic Update
Viale, P., & Stefani, S. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.3.235 · Cited by 66
Prioritizing risks of antibiotic resistance genes in all metagenomes
Martínez, J. L., Coque, T. M., & Baquero, F. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3399-c2 · Cited by 58
Rajendran, R., Borghi, E., Falleni, M., Perdoni, F., Tosi, D., Lappin, D. F., O’Donnell, L. E., Greetham, D., Ramage, G., & Nile, C. J. (2015) · Eukaryotic Cell · doi:10.1128/ec.00067-15 · Cited by 62
“Bloodstream infections caused by Candida species remain a frequent cause of morbidity and mortality, particularly within the immunocompromised population (1, 2).”
BackgroundNash, E. E., Peters, B. M., Fidel, P. L., & Noverr, M. C. (2015) · Infection and Immunity · doi:10.1128/iai.01059-15 · Cited by 65
“They are the most common causative agents of late-onset sepsis in very-low-birth-weight infants (19) and are rated among the top four pathogens causing bloodstream infections (20).”
BackgroundBurgmann, H., Hiesmayr, J. M., Savey, A., Bauer, P., Metnitz, B., & Metnitz, P. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1941-2 · Cited by 57
Adamo, R., Tontini, M., Brogioni, G., Romano, M. R., Costantini, G., Danieli, E., Proietti, D., Berti, F., & Costantino, P. (2011) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2011.604453 · Cited by 63
Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 57
“Pfaller MA, Diekema DJ: Epidemiology of invasive mycoses in North America.”
BackgroundInfluentialSohail, M. R., Palraj, R., Khalid, S., Uslan, D. Z., Al‐Saffar, F., Friedman, P. A., Hayes, D. L., Lohse, C. M., Wilson, W. R., Steckelberg, J. M., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002199 · Cited by 63
“settings and is associated with significant morbidity and mortality.(1,2) Staphylococcus aureus bacteremia (SAB) in cardio-”
Wiederhold, N. P., & Lewis, J. S. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1155 · Cited by 59
“In the US, Candida species are the fourth most common organisms isolated from patients with nosocomial bloodstream infections [1].”
BackgroundSingh, S., Fatima, Z., & Hameed, S. (2016) · Archives of Microbiology · doi:10.1007/s00203-016-1205-9 · Cited by 63
Liao, G., Zhou, Z., Burgula, S., Liao, J., Yuan, C., Wu, Q., & Guo, Z. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500575a · Cited by 61
“In an effort to systematically explore the structure-immunogenicity relationships of linear βglucans and optimize the antigen design for creating more efficacious antifungal vaccines, we have: (1) developed a highly convergent and effective method for the synthesis of oligosaccharides of β-glucan with varied chain len…”
MethodYan, H., Rengert, Z. D., Thomas, A. W., Rehermann, C., Hinks, J., & Bazan, G. C. (2016) · Chemical Science · doi:10.1039/c6sc00630b · Cited by 61
Lu, H. D., Yang, S. S., Wilson, B. K., McManus, S. A., Chen, C. V. H.-H., & Prud’homme, R. K. (2017) · Applied Nanoscience · doi:10.1007/s13204-017-0548-0 · Cited by 61
“These trends provide the impetus to develop new and improved methods to treat bacterial infections (Holmes et al. 2016; Ventola 2015a, b; Viswanathan 2014; Wisplinghoff et al. 2004).”
BackgroundGuillamet, C. V., Vazquez, R., Micek, S. T., & Kollef, M. H. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix612 · Cited by 62
Sinnollareddy, M., Peake, S. L., Roberts, M. S., Lipman, J., & Roberts, J. A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.07.013 · Cited by 56
“C ir rh ot ic li ve r p at ie n t [4 5] 19 .”
BackgroundTojo, M., Fujita, T., Ainoda, Y., Nagamatsu, M., Hayakawa, K., Mezaki, K., Sakurai, A., Masui, Y., Yazaki, H., Takahashi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094064 · Cited by 56
“The National Healthcare Safety Network at CDC reported that a significant proportion of central line-associated bloodstream infections are caused by drug-resistant Gram-negative pathogens in the USA [31].”
ResultProbiotics and their postbiotics for the control of opportunistic fungal pathogens: A review
Divyashree, S., Shruthi, B., Vanitha, P. R., & Sreenivasa, M. Y. (2023) · Biotechnology Reports · doi:10.1016/j.btre.2023.e00800 · Cited by 66
Laupland, K. B., Parkins, M. D., Gregson, D. B., Church, D. L., Ross, T., & Pitout, J. D. D. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0400-7 · Cited by 61
“Furthermore, multicentered surveys have indicated that Serratia species are among the top ten causes of nosocomial bloodstream infection [8].”
Adrenomedullin reduces Staphylococcus aureus α-toxin–induced rat ileum microcirculatory damage
Brell, B., Temmesfeld‐Wollbrück, B., Altzschner, I., Frisch, E., Schmeck, B., Hocke, A. C., Suttorp, N., & Hippenstiel, S. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000159194.53695.7a · Cited by 57
The SUN41 and SUN42 genes are essential for cell separation in Candida albicans
Firon, A., Aubert, S., Iraqui, I., Guadagnini, S., Goyard, S., Prévost, M., Janbon, G., & D'Enfert, C. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.06011.x · Cited by 56
“Candida albicans is currently responsible for a significant fraction of fungal infections in otherwise healthy individuals and for the majority of fungal infections contracted in the hospital environment (Wisplinghoff et al., 2004).”
BackgroundWong, S. S. W., Samaranayake, L. P., & Seneviratne, C. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.009 · Cited by 64
Hsu, D. I., Nguyen, M., Nguyen, L., Law, A. V., & Wong‐Beringer, A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq216 · Cited by 62
Chong, P., Chin, V., Wong, W., Madhavan, P., Yong, V., & Looi, C. (2018) · Genes · doi:10.3390/genes9110540 · Cited by 57
“albicans is the third most commonly isolated microbe from bloodstream infections among hospitalized patients in the US [1].”
BackgroundDysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia
Rashidi, A., Kaiser, T., Shields‐Cutler, R. R., Graiziger, C. T., Holtan, S. G., Rehman, T. U., Wasko, J. A., Weisdorf, D. J., Dunny, G. M., Khoruts, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42652-6 · Cited by 64
The biofilm adhesion protein Aap from Staphylococcus epidermidis forms zinc-dependent amyloid fibers
Yarawsky, A. E., Johns, S. L., Schuck, P., & Herr, A. B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010874 · Cited by 59
“epidermidis specifically is the leading cause of nosocomial infections and device-related infections (2, 3) and is, along with its other coagulase-negative relatives, the leading cause of bacteremia (4, 5).”
BackgroundInitial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines
Patel, M., Kunz, D. F., Trivedi, V. M., Jones, M. G., Moser, S. A., & Baddley, J. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.12.010 · Cited by 58
“albicans species are increasing in frequency, and often have varying degrees of antifungal susceptibility, thereby complicating the choice of initial antifungal therapy (Wisplinghoff et al., 2004; Pappas et al., 2003; Trick et al., 2002; Rangel-Frausto et al., 1999; Kao et al., 1999; Viscoli et al., 1999).”
BackgroundPaiva, L. C. F., Vidigal, P. G., Donatti, L., Svidzinski, T. I. E., & Consolaro, M. E. L. (2012) · Micron · doi:10.1016/j.micron.2011.09.013 · Cited by 55
Kobayashi, S., Hira, D., Yoshida, K., Toyofuku, M., Shida, Y., Ogasawara, W., Yamaguchi, T., Araki, N., & Oshiki, M. (2018) · Microbes and Environments · doi:10.1264/jsme2.me18058 · Cited by 56
Baker, C. P., Bruderer, R., Abbott, J., Arthur, J. S. C., & Brenes, A. J. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00671 · Cited by 62
A universal TagModule collection for parallel genetic analysis of microorganisms
Oh, J., Fung, E., Price, M. N., Dehal, P., Davis, R. W., Giaever, G. N., Nislow, C., Arkin, A. P., & Deutschbauer, A. M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq419 · Cited by 56
“Candida albicans is one of the most common causes of nosocomial infections (8) with a high rate of acquired drug resistance (9).”
BackgroundCandidainfection and colonization among non-trauma emergency surgery patients
Kourkoumpetis, T. K., Manolakaki, D., Velmahos, G. C., Chang, Y., Alam, H. B., Moya, M. M. D., Sailhamer, E. A., & Mylonakis, E. E. (2010) · Virulence · doi:10.4161/viru.1.5.12795 · Cited by 70
Remuzgo‐Martínez, S., Lázaro-Díez, M., Mayer, C., Aranzamendi, M., Padilla, D., Jorge, C., Marco, F., Martínez-Martínez, L., Icardo, J. M., Otero, A., et al. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00088-15 · Cited by 59
Smeekens, S. P., Gresnigt, M. S., Becker, K. L., Cheng, S.-C., Netea, S. A., Jacobs, L., Jansen, T., van de Veerdonk, F. L., Williams, D. L., Joosten, L. A. B., et al. (2015) · Cytokine · doi:10.1016/j.cyto.2014.10.013 · Cited by 55
“Colonization with Candida does not cause disease in healthy individuals, but in patients in whom the immune system is compromised Candida can cause severe mucosal and systemic infections, the latter with a mortality rate reaching up to 30–40% [1].”
Solheim, M., Brekke, M. C., Snipen, L. G., Willems, R. J. L., Nes, I. F., & Brede, D. A. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-3 · Cited by 57
“faecalis has gained notoriety as one of the primary causative agents of nosocomial infections [1,2], including urinary tract infections, endocarditis, intra-abdominal infections and bacteremia.”
BackgroundSoldera, J., Nedel, W. L., Cardoso, P. R. C., & d’Azevedo, P. A. (2013) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802013000100010 · Cited by 55
Goodreid, J. D., Janetzko, J., Maria, J. P. S., Wong, K. S., Leung, E., Eger, B. T., Bryson, S., PAI, E. F., Gray‐Owen, S. D., Walker, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01451 · Cited by 61
Mortality and risk factor analysis for Candida blood stream infection: A multicenter study
Kato, H., Yoshimura, Y., Suido, Y., Shimizu, H., Ide, K., Sugiyama, Y., Matsuno, K., & Nakajima, H. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.01.002 · Cited by 61
Diagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 72
Chen, L., Wang, Z., Liu, L., Qu, S., Mao, Y., Peng, X., Li, Y.-X., & Tian, J. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10119-3 · Cited by 58
Antifungal resistance in patients with Candidaemia: a retrospective cohort study
Aldardeer, N. F., Albar, H., Alattas, M., Eldali, A., Qutub, M., Hassanien, A., & Alraddadi, B. M. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-019-4710-z · Cited by 67
Salazar, S. B., Simões, R., Pedro, N. A., Pinheiro, M. J. F., Carvalho, M. F. N. N., & Mira, N. P. (2020) · Journal of Fungi · doi:10.3390/jof6010023 · Cited by 63
Shariati, A., Moradabadi, A., Chegini, Z., Khoshbayan, A., & Didehdar, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s254478 · Cited by 64
“Candidiasis Candida species are one of the most frequent isolated nosocomial agents that can involve various organs, particularly eyes, liver, kidney, and brain in patients with hematological malignancies such as acute leukemia, lymphoma, and myelodysplastic syndrome.(79) The most common members of this species that a…”
BackgroundMigiyama, Y., Yanagihara, K., Kaku, N., Harada, Y., Yamada, K., Nagaoka, K., Morinaga, Y., Akamatsu, N., Matsuda, J., Izumikawa, K., et al. (2015) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2014.573 · Cited by 57
Ghannoum, M. A., Chen, A. W., Buhari, M. A., Chandra, J., Mukherjee, P. K., Baxa, D. M., Golembieski, A., & Vázquez, J. A. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02660.x · Cited by 57
“Approximately half of the cases of candidaemia are due to non-albicans species, such as Candida glabrata, Candida parapsilosis and Candida tropicalis [1–3].”
BackgroundCandida glabrata fungaemia in intensive care units
Ruan, S., Lee, L., Jerng, J., Yu, C., & Hsueh, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01892.x · Cited by 59
“The outcome of ICU patients with candidaemia is poor, with mortality ranging from 47% to 58% in previous studies [1,10].”
BackgroundResultDiagnosis and Outcome of Early Pleural Space Infection Following Lung Transplantation
Wahidi, M. M., Willner, D. A., Snyder, L. D., Hardison, J. L., Chia, J. Y., & Palmer, S. M. (2008) · CHEST Journal · doi:10.1378/chest.08-1339 · Cited by 55
The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis
Burke, Ó., Zeden, M. S., & O’Gara, J. P. (2024) · Virulence · doi:10.1080/21505594.2024.2359483 · Cited by 64
In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species
Bonilla, J. J. A., Guerrero, D. J. P., Sánchez, C. I., López, C. C. O., & Torres, R. G. (2015) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-015-1933-z · Cited by 58
Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata
G-Dayanandan, N., Paulsen, J. L., Viswanathan, K., Keshipeddy, S. K., Lombardo, M. N., Zhou, W., Lamb, K. M., Sochia, A. E., Alverson, J. B., Priestley, N. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401916j · Cited by 59
Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens
Grgurich, P. E., Hudcova, J., Lei, Y., Sarwar, A., & Craven, D. E. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.45 · Cited by 64
Detection of Fifteen Species of Candida in an Automated Blood Culture System
Horvath, L. L., George, B. J., & Hospenthal, D. R. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00966-07 · Cited by 64
“Candida species are the fourth most common cause of nosocomial bloodstream infections in the United States (23).”
BackgroundInfecciones relacionadas con el uso de los catéteres vasculares
Ferrer, C., & Almirante, B. (2014) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.12.002 · Cited by 68
Pitman, S. K., Drew, R. H., & Perfect, J. R. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.607811 · Cited by 54
“This represented the fourth leading cause of such infections [1].”
BackgroundSchmidt, V. M., Williams, N. J., Pinchbeck, G. L., Corless, C. E., Shaw, S., McEwan, N. R., Dawson, S., & Nuttall, T. J. (2014) · BMC Veterinary Research · doi:10.1186/1746-6148-10-17 · Cited by 54
“MDR among CoNS isolates is widely reported [15,49,72,73,91] and may be associated with the carriage of multiple antimicrobial resistance genes on SCCmec cassettes [40].”
BackgroundMarschall, J. (2010) · Infection and Drug Resistance · doi:10.2147/idr.s10105 · Cited by 62
“108 They are also the most common skin flora associated with blood culture contamination.”
Mestas, J., Polanco, C. M., Felsenstein, S., & Bard, J. D. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02322-13 · Cited by 54
Li, H. K., Scarborough, M., Zambellas, R., Cooper, C., Rombach, I., Walker, A. S., Lipsky, B. A., Briggs, A. H., Seaton, A., Atkins, B. L., et al. (2015) · Trials · doi:10.1186/s13063-015-1098-y · Cited by 54
“The latter carries with it a crude mortality estimate of up to 25 % [28].”
BackgroundReal-Time Detection of Staphylococcus Aureus Using Whispering Gallery Mode Optical Microdisks
Ghali, H., Chibli, H., Nadeau, J., Bianucci, P., & Peter, Y.-A. (2016) · Biosensors · doi:10.3390/bios6020020 · Cited by 56
“Overuse of antibiotics has given rise to antibiotic-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA), which is responsible for over 60% of staphylococcal infections in hospitals [2,3].”
BackgroundLee, A. S., White, E. B., Monahan, L. G., Jensen, S. O., Chan, R., & van Hal, S. J. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.29 · Cited by 54
“To minimize the impact of these assumptions, we limited this analysis to isolates from (1) the single dominant cluster (cluster 1) and (2) those obtained within a ±2 month window from the time of the environmental sampling, based on previous observations of VRE survival on surfaces for up to 2 months.”
MethodJaeger, M., Pinelli, M., Borghi, M., Costantini, C., Dindo, M., van Emst, L., Puccetti, M., Pariano, M., Ricaño-Ponce, I., Büll, C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aar3558 · Cited by 62
“Although Candida is a commensal in most of the healthy population, dysregulation or defects in host defense mechanisms can lead to infection by Candida species (1, 2).”
BackgroundReller, M. E., Mallonee, A. B., Kwiatkowski, N. P., & Merz, W. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01127-07 · Cited by 60
“Although Candida albicans remains the most common isolate, nearly half of all invasive infections are now caused by other species (7, 8).”
BackgroundIdentification of Acinetobacter baumannii Serum-Associated Antibiotic Efflux Pump Inhibitors
Blanchard, C. E., Barnett, P., Perlmutter, J. I., & Dunman, P. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03535-14 · Cited by 54
“baumannii infection, both of which are thought to include dissemination of the organism to visceral organs via the circulatory system (1, 2, 6, 37).”
BackgroundAnderson, M. Z., Saha, A., Haseeb, A., & Bennett, R. J. (2017) · Microbiology · doi:10.1099/mic.0.000478 · Cited by 53
“Reports of resistance to fluconazole have increased due to more frequent use of immunosuppression and antifungal prophylaxis [11, 12].”
BackgroundCandida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 77
Pellizzer, G., Mantoan, P., Timillero, L., Allegranzi, B., Fedeli, U., Schievano, E., Benedetti, P., Saïa, M., Sax, H., & Spolaore, P. (2008) · Infection · doi:10.1007/s15010-007-7092-x · Cited by 53
Gröbner, S., Dion, M., Plante, M., & Kempf, V. A. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02179-08 · Cited by 54
“MSSA (45) 0 42 3 0 0 45 0 MRSA (45) 0 2 43 0 0 0 45 CoNS (19) 19 0 0 11 8 0 0 Total (109) 19 44 46 11 8 45 45”
Sava, I. G., Zhang, F., Toma, I., Theilacker, C., Li, B., Baumert, T. F., Holst, O., Linhardt, R. J., & Hüebner, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901460200 · Cited by 55
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.